NO20052474D0 - Amort form av esomeprazolsalter - Google Patents

Amort form av esomeprazolsalter

Info

Publication number
NO20052474D0
NO20052474D0 NO20052474A NO20052474A NO20052474D0 NO 20052474 D0 NO20052474 D0 NO 20052474D0 NO 20052474 A NO20052474 A NO 20052474A NO 20052474 A NO20052474 A NO 20052474A NO 20052474 D0 NO20052474 D0 NO 20052474D0
Authority
NO
Norway
Prior art keywords
amortized
esomeprazole
salts
esomeprazole salts
amortized form
Prior art date
Application number
NO20052474A
Other languages
English (en)
Other versions
NO20052474L (no
Inventor
Yatendra Kumar
Mohan Prasad
Mahavir Singh Khanna
Bakthavathsalan Vijayaraghavan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of NO20052474D0 publication Critical patent/NO20052474D0/no
Publication of NO20052474L publication Critical patent/NO20052474L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20052474A 2002-10-22 2005-05-23 Amort form av esomeprazolsalter NO20052474L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1057DE2002 2002-10-22
PCT/IB2003/004662 WO2004037253A1 (en) 2002-10-22 2003-10-22 Amorphous form of esomeprazole salts

Publications (2)

Publication Number Publication Date
NO20052474D0 true NO20052474D0 (no) 2005-05-23
NO20052474L NO20052474L (no) 2005-05-23

Family

ID=32170658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052474A NO20052474L (no) 2002-10-22 2005-05-23 Amort form av esomeprazolsalter

Country Status (8)

Country Link
US (2) US20040235903A1 (no)
EP (1) EP1556043A1 (no)
CN (1) CN1728997A (no)
AU (1) AU2003278406A1 (no)
BR (1) BR0315574A (no)
EA (1) EA200500673A1 (no)
NO (1) NO20052474L (no)
WO (1) WO2004037253A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105054A1 (en) * 2004-04-15 2005-11-10 Dr. Reddy's Laboratories Ltd. Dosage form having polymorphic stability
CN103772360A (zh) 2004-06-24 2014-05-07 阿斯利康(瑞典)有限公司 制备用于制备艾美拉唑钠盐的结晶修饰物的新方法
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20080146615A1 (en) * 2004-12-20 2008-06-19 Dr. Reddy's Laboratories Limited Pharmaceutical Compositions Comprising Amorphous Benzimidazole Compounds
WO2006067599A2 (en) 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
DE102005008412A1 (de) * 2005-02-24 2006-09-07 Ratiopharm Gmbh Piperazinsalz des Omeprazols und dessen Enantiomere
WO2006096709A2 (en) * 2005-03-08 2006-09-14 Dr. Reddy's Laboratories Ltd. Process for preparing amorphous salts
EP1904064A4 (en) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr OMEPRAZOLE OF FORM B
WO2007031845A2 (en) * 2005-09-14 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
US20090082572A1 (en) * 2005-11-14 2009-03-26 Hetero Drugs Limited Process for amorphous esomeprazole
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
CA2631919A1 (en) 2005-12-05 2007-06-14 Astrazeneca Ab New process for the preparation of esomeprazole non-salt form
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
ES2355164T3 (es) * 2006-06-07 2011-03-23 Astrazeneca Ab Nuevo método para la preparación de sales de amonio de esomeprazol.
WO2008092939A2 (en) 2007-01-31 2008-08-07 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
NZ579136A (en) 2007-02-21 2012-05-25 Cipla Ltd Process for the preparation of esomeprazole magnesium dihydrate
EP2195309A4 (en) * 2007-10-08 2013-04-24 Hetero Drugs Ltd SALT POLYMORPHS OF THE ESOMEPRAZOLE
US8911787B2 (en) 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
WO2010097583A1 (en) * 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
WO2011095984A1 (en) * 2010-02-02 2011-08-11 Glenmark Generics Limited A process for the preparation of amorphous esomeprazole
FR3062129B1 (fr) * 2017-01-23 2019-04-05 Minakem Procede d'obtention du sel de magnesium dihydrate de l'esomeprazole
CN113387929A (zh) * 2021-06-30 2021-09-14 江苏中邦制药有限公司 一种艾司奥美拉唑镁三水合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
CA2180535C (en) * 1994-01-05 2004-03-23 Lindberg, Per Lennart A method for treatment of psoriasis, by omeprazole or related compounds
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
US6124816A (en) * 1998-06-02 2000-09-26 Cirrus Logic, Inc. One bit digital to analog converter with relaxed filtering requirements
US6262085B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
AU5248601A (en) * 2000-05-15 2001-11-26 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts
CA2417311C (en) * 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
IL159854A0 (en) * 2001-07-16 2004-06-20 Janssen Pharmaceutica Nv Improved process for preparing benzimidazole-type compounds
WO2004002982A2 (en) * 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
US7651788B2 (en) 2003-03-05 2010-01-26 Lg Display Co., Ltd. Organic electroluminescent device

Also Published As

Publication number Publication date
US20040235903A1 (en) 2004-11-25
EA200500673A1 (ru) 2005-12-29
BR0315574A (pt) 2005-09-20
NO20052474L (no) 2005-05-23
US20080119654A1 (en) 2008-05-22
EP1556043A1 (en) 2005-07-27
AU2003278406A1 (en) 2004-05-13
CN1728997A (zh) 2006-02-01
WO2004037253A1 (en) 2004-05-06
US7482463B2 (en) 2009-01-27

Similar Documents

Publication Publication Date Title
NO20052474D0 (no) Amort form av esomeprazolsalter
LU92504I2 (fr) Fluopyram
ATE505471T1 (de) Azaindol-kinaseinhibitoren
ATE389374T1 (de) Zwischenwirbelimplantat
ATE390898T1 (de) Zwischenwirbelimplantat
ATE394087T1 (de) Zwischenwirbelimplantat
ATE394086T1 (de) Zwischenwirbelimplantat
ATE380544T1 (de) Umhüllte feste darreichungsform
DE60220661D1 (de) Transdermales pflaster zur verabreichung von fentanyl
ATE455767T1 (de) Heterozyklische vegfr-2 kinase inhibitoren
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
DE602004018837D1 (de) Ptidase-iv-inhibitoren
IS8399A (is) Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns
DE60317243D1 (de) Weiterreichung zwischen domänen
DK1996744T3 (da) Fremgangsmåder til antimikrobiel coating
SE0303324L (sv) Implantat
NO20044188L (no) Kontrollerte frigjoringsdoseformer
FR2843017B1 (fr) Implant inter-somatique
SE0303322L (sv) Implantat
DE10393292D2 (de) Holzmantel
DE502004004196D1 (de) Ultraschall-stehwellen-zerstäuberanordnung
DE60323088D1 (de) Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin
NO20033160D0 (no) Anordning for behandling av gravann
ATA14982002A (de) Ziegel
FI20022065A (fi) Hammaselimen regeneraatio